Cristina Agulló is a Clinical Laboratory Specialist in the protein area of the Analysis and Clinical Biochemistry Department in Salamanca’s University Hospital. She obtained her biology degree from the University of Alicante and completed her residency in Analysis and Clinical Biochemistry at the University Hospital of Salamanca, Spain. She is a PhD student in the Department of Medicine at the University of Salamanca, in Spain, where she is currently developing a research project regarding the identification of monoclonal proteins by mass spectrometry with the methodology QIP-MS (quantitative immunoprecipitation mass spectrometry) in patients with multiple myeloma and other monoclonal gammopathies.
Agulló works in the protein section of the University Hospital of Salamanca, mainly focused on monoclonal gammopathies, and she is also carrying out her PhD project on QIP-MS, performed with the EXENT Solution Technology from Binding Site, part of Thermofisher. She undertook a stay of two months at the Protein Immunology and Proteomics department in Mayo Clinic Laboratories in Rochester (Minnesota, EEUU) as an observer trainee. This group is a pioneer in the development of this methodology, and she learnt there how to use it to analyze the monoclonal proteins, specifically by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).
She is also a member of the Protein Commission of the Spanish Society for Laboratory Medicine (SEQC).
Cristina Agulló is a Clinical Laboratory Specialist in the protein area of the Analysis and Clinical Biochemistry Department in Salamanca’s University Hospital. She obtained her biology degree from the University of Alicante and completed her residency in Analysis and Clinical Biochemistry at the University Hospital of Salamanca, Spain. She is a PhD student in the Department of Medicine at the University of Salamanca, in Spain, where she is currently developing a research project regarding the identification of monoclonal proteins by mass spectrometry with the methodology QIP-MS (quantitative immunoprecipitation mass spectrometry) in patients with multiple myeloma and other monoclonal gammopathies.
Agulló works in the protein section of the University Hospital of Salamanca, mainly focused on monoclonal gammopathies, and she is also carrying out her PhD project on QIP-MS, performed with the EXENT Solution Technology from Binding Site, part of Thermofisher. She undertook a stay of two months at the Protein Immunology and Proteomics department in Mayo Clinic Laboratories in Rochester (Minnesota, EEUU) as an observer trainee. This group is a pioneer in the development of this methodology, and she learnt there how to use it to analyze the monoclonal proteins, specifically by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).
She is also a member of the Protein Commission of the Spanish Society for Laboratory Medicine (SEQC).